“What if we could harness the electrical activity within our biological systems to redefine healthcare?” — Samir S. Awad, MD, Medical Director, Electrome
Introduction
The management of infections remains one of medicine’s most pressing challenges, particularly as antimicrobial resistance rises and new pathogens emerge. Chronic wounds, persistent bacterial and viral infections, and hospital-acquired illnesses not only cause suffering and high costs, but also strain health systems worldwide (1,2). While antimicrobials remain essential, bioelectric medicine is rapidly establishing itself as a complementary approach, harnessing the body’s own electrical language to stimulate healing, control inflammation, and overcome pathogens (3,4,5).
Electrome is positioned at this intersection of immunology, neuromodulation, and biomedical engineering, aiming to make bioelectric solutions a new standard in infection management.
The electrical basis of immunity and infection
Infection and wound repair are fundamentally bioelectric processes. At sites of injury, endogenous electrical gradients emerge that guide immune cell migration, tissue repair, and pathogen clearance (3,6). Membrane potentials influence cell activation, cytokine production, and the directed movement of neutrophils and macrophages into infected tissue (3). Properly guided, these signals accelerate immune responses and support more efficient healing.
Recent advances in neuroimmunology confirm that bioelectric cues orchestrate much of the “neural-immune axis,” the communication channel through which nerves modulate immune function (3,7). Experimental therapies that stimulate the vagus nerve, for example, have been shown to suppress excessive inflammation, promote tissue repair, and reduce disease severity in both preclinical and clinical studies (3,5,7).
Electrome’s approach: technology, individualization, and discovery
Electrome integrates real-time electrophysiological mapping, closed-loop feedback stimulation, and immune-response modeling to design individualized bioelectric therapies. This data-driven approach allows the company to identify the most effective electrical signatures for each infection type (1,8).
Medical Director Dr. Samir Awad emphasizes the translational potential:
“What if we could harness the electrical activity within our biological systems to redefine healthcare?”
Electrome’s research pipeline includes wearable and implantable devices calibrated for acute and chronic infections. Proprietary studies show enhanced bacterial clearance, faster wound epithelialization, and reduced scarring when bioelectric interventions complement antibiotic therapy (4,5,8).
Mechanisms: how bioelectric therapy impacts infection
Bioelectric modulation works through multiple interconnected mechanisms. Applied electrical fields can direct leukocytes into infected tissues, enhancing innate defense (3,4,5). Vagus nerve stimulation reduces production of pro-inflammatory cytokines such as TNF-α and IL-6, limiting systemic inflammation and collateral tissue damage (5,7). Local currents improve perfusion and oxygenation, giving immune cells better access to infected tissue (7). Electrical stimulation also enhances the effectiveness of antimicrobials, improving penetration, disrupting biofilms, and overcoming resistance (3,6,8). At the wound level, bioelectricity regulates pH, ionic balance, and redox conditions, creating an optimized microenvironment for repair (3,5,8).
Clinical implementation: protocols, safety, and outcomes
In practical settings, Electrome’s bioelectric dressings and feedback-controlled stimulators are applied early, often alongside antimicrobial therapy (8). Clinical safety data are robust, with no significant adverse effects reported (4,9). Protocol refinements guided by real-world data and machine learning further individualize therapy according to infection type, patient physiology, wound location, and comorbidities (1,2,8).
Chief Operating Officer Dr. Wanni Davis highlights the patient-centered value:
“Understanding how bioelectric properties influence regeneration can help us develop more effective treatment protocols. By unlocking the body’s regenerative capacity through electrical signals, we provide innovative solutions to previously hard-to-treat conditions.”
Beyond wounds: systemic infections and future horizons
While wound healing is a leading application, bioelectric therapy extends well beyond the skin. Clinical trials are underway in osteomyelitis, device-associated infections, and systemic inflammatory diseases (8,10). Neuromodulation techniques, such as vagus nerve stimulation, have shown promising effects in sepsis, autoimmune disorders, and rheumatoid arthritis (3,5,7,11,12). Emerging preclinical studies suggest potential applications for viral infections, including respiratory and neuroinvasive diseases, by modulating host immune responses (3,7).
Economic and public health ramifications
Globally, wound care and infection management generate billions in costs, hospital stays, and lost productivity each year (9,10). Standard treatments are often prolonged, particularly for patients with chronic conditions. By accelerating healing and reducing complications, bioelectric solutions can generate substantial system-wide savings (1,10).
Remote monitoring and home-based care enabled by Electrome’s devices further reduce the burden on hospitals, while extending access to advanced therapies in underserved regions.
Research, development, and Electrome’s future
Electrome collaborates with academic institutes, infection-control centers, and hospital networks to ensure robust validation and optimization of bioelectric protocols (1,8). With expertise in scalable device engineering and regulatory compliance, the company is positioned to deploy next-generation therapies globally.
The future includes AI-powered systems capable of predicting infection risk and generating personalized stimulation protocols for preventive care, particularly in high-risk populations.
Conclusion
Bioelectric medicine is redefining infection management. By accelerating recovery, supporting immune resilience, and complementing antimicrobial strategies, Electrome is leading the charge to establish bioelectric therapies as a standard of care worldwide.
References
- Bioelectronic Medicine: a multidisciplinary roadmap from biophysics to patient care. Front Integr Neurosci. 2024;18:1321872. Link
- Next-Generation Bioelectric Medicine: Harnessing the Therapeutic Potential. Front Neurol. 2020;11:616529. Link
- Bioelectronic Medicine in Treatment of Chronic Inflammatory Disease. Front Immunol. 2019;10:3243. Link
- Bioelectric Therapy for Treating Painful Conditions. WebMD. 2024. Link
- Novel Bioelectronic Medicine for Rheumatoid Arthritis: A Review. American Pharmaceutical Review. 2025. Link
- SetPoint Medical – Start Activating. Link
- The rise of bioelectric medicine sparks interest among researchers. PNAS. 2019;116(49):24379-24381. Link
- 8 Companies Developing Bioelectronic Devices. Nanalyze. Link
- Bioelectronic Medicine Market Research Report 2025. GlobeNewswire. 2025.
- Electroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion Globally by 2032. Allied Market Research. 2024. Link
- Non-Invasive Ultrasound Treatment Shows Promise for Neuropathic Pain Relief. Feinstein Institutes/BioSpace. 2025. Link
- Novel Bioelectronic Medicine for Rheumatoid Arthritis: A Review. American Pharmaceutical Review. 2025. Link
What Comes Next: Scaling Bioelectric Frontiers
In Bioelectric Science, Vol. VI, we will explore how bioelectric modulation can extend beyond infection control into broader systemic resilience—bridging immunology, neurology, and regenerative medicine in ways that could transform global public health.
Bioelectric Science Series Recap
Vol. I: The Future is Electric
Vol. II: The Signal Effect
Vol. III: Electric Immunity
Vol. IV: The Personalized Pulse
Vol. V: The Electric Brain
Vol. VI: Harnessing Bioelectricity to Combat Infection
Vol. VII: Signals of the Self — Bioelectricity, Consciousness, and Human Enhancement
Electrome: Bioelectric Science Series is published by Electrome Corporation as a frontier journal and cultural signal for the emerging field of frequency-based medicine. To collaborate, invest, or license, visit www.electrome.com.